NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Park Medi World Shares Reach New High

Key Highlights:

  • Park Medi World shares reached a 52-week high of Rs 208.72 per share on the National Stock Exchange (NSE), up 3.46%.
  • The gains follow the company's announcement to launch a new multi-speciality hospital at Panchkula and expand capacity at its Mohali facility.

Business Updates:

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

  • The Park Medi World board of directors approved the launch of a multi-speciality hospital at Panchkula on March 29, 2026.
  • The board also approved the addition of 150 beds at Grecian Super Speciality Hospital in Mohali, increasing total bed capacity to 500 from 350.
  • The Mohali hospital is operated by RGS Healthcare, a subsidiary of Park Medi World.

Company History:

  • Park Medi World made its market debut in December 2025, listing at Rs 155.60 per share on the Bombay Stock Exchange (BSE).
  • The company launched its initial public offering (IPO) to raise Rs 920 crore through a fresh issue of 4.75 crore shares worth Rs 770 crore and an offer for sale (OFS) of shares worth Rs 150 crore by promoter Ajit Gupta. The IPO price band was Rs 154-162 per share.

Investor Takeaway

Investors should be aware of Park Medi World's expansion plans, which may positively impact the company's stock price in the short term.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.